Palisade Bio, Inc. Common Stock (PALI) is a publicly traded Healthcare sector company. As of July 10, 2026, PALI trades at $1.95 with a market cap of $356.25M and a P/E ratio of -6.56. PALI moved -1.27% today. Year to date, PALI is -16.17%; over the trailing twelve months it is +159.21%. Its 52-week range spans $0.53 to $3.30. Analyst consensus is strong buy with an average price target of $10.80. Rallies surfaces PALI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PALI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.95 |
| Market Cap | $356.25M |
| P/E Ratio | -6.56 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.30 |
| 52-Week Low | $0.53 |
| Volume | 1.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.78M |
| Gross Margin | 0.00% |
5 analysts cover PALI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.80.